
Phimo International has released its third quarter 2022 and year-to-date performance report, revealing that PMI's net income has declined by 1.1% in Q3.
In the third quarter, the net revenue from smoke-free products accounted for 30.1% of the total net revenue. The market share of IQOS, a heated tobacco device (HTU), increased by 1.3 percentage points to 7.7% in the IQOS market. At the end of the quarter, the estimated total number of IQOS users was around 19.5 million (an increase of 3.6 million or 22% compared to September 30, 2021), of which about 13.5 million have switched to IQOS and quit smoking. The company will increase its quarterly dividend by 1.6% to $1.27 per share, or $5.08 per share on an annual basis.
For the first nine months of this year, the net income from new tobacco accounted for 30.4% of the total net income. HTU's market share in the IQOS market has increased by 1.2 percentage points to 7.6%.
Jacek Olczak, CEO of PMI, stated in a press release that the company achieved strong performance in the third quarter, despite pressures related to currency, supply chains, and inflation. Adjusted earnings per share for the quarter reached $1.53.
During this quarter, IQOS has continued to experience positive momentum, as the number of heated tobacco units and market share has increased in all major regions, partially due to the strong performance of ILUMA upon initial release. Furthermore, the strong performance of our combustible tobacco product portfolio has supplemented this trend, reflecting stable shipment volumes and encouraging growth in international market share and pricing acceleration.
Due to our strong performance from the beginning of the year, we have raised the lower end of our full-year adjusted net income growth outlook to between 6.5% and 8%, with organic growth. Additionally, we expect adjusted earnings per share to increase by 10% to 12% for the year, excluding currency.
Statement:
This article is compiled from third-party information and is intended solely for industry exchange and learning.
This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of its contents. The translation of this article is solely for industry-related communication and research purposes.
Due to limitations in translation ability, the translated article may vary in expression compared to the original. Please refer to the original article for accuracy.
Regarding any domestic, Hong Kong, Macau, Taiwan, or international issues, 2FIRSTS aligns fully with the stance of the Chinese government.
Compilation of information is subject to the copyright of the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.









